Novabridge Biosciences ADR
(NBP)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 0 | 7,114 | 5,266 | 13,371 | 12,412 |
| Operating Income | N/A | -7,114 | -5,266 | -13,371 | -12,412 |
| Other Income | 0 | 1,610 | 2,116 | 2,527 | -8,079 |
| Pre-tax Income | 0 | -5,504 | -3,150 | -10,844 | -20,491 |
| Net Income Continuous | N/A | -5,504 | -3,150 | -10,844 | -20,491 |
| Net Income | $N/A | $-5,504 | $-3,150 | $-10,844 | $-20,491 |
| EPS Basic Total Ops | N/A | -0.07 | -0.04 | -0.12 | -0.25 |
| EPS Basic Continuous Ops | N/A | -0.07 | -0.04 | -0.13 | -0.25 |
| EPS Diluted Total Ops | N/A | -0.07 | -0.04 | -0.12 | -0.25 |
| EPS Diluted Continuous Ops | N/A | -0.07 | -0.04 | -0.13 | -0.25 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.07 | -0.04 | N/A | -0.25 |
| EBITDA(a) | $N/A | $-7,114 | $-5,266 | $-13,371 | $-12,412 |